This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

OIG Advisory Opinion 25-12

The Office of Inspector General ("OIG") recently issued OIG Advisory Opinion 25-12 (the "Opinion") addressing a home care agency's ("Agency's") plan to offer and advertise sign...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Consolidated Appropriations Act Of 2026 Requires Greater Transparency By Pharmacy Benefit Managers

On February 3, 2026, Congress passed and President Trump signed into law the Consolidated Appropriations Act of 2026 (CAA).

United States Healthcare

GB

Genova Burns

California Food Fight: The SF City Attorney's Snack Attack

San Francisco's City Attorney has sued 11 major food companies, alleging they engineered ultra-processed foods to be addictive, concealed health risks, and targeted children and minority communities...

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Authenticity in Alcohol Labeling: What's Brewing?

In recent years, the alcohol beverage industry has faced a growing wave of consumer false advertising lawsuits alleging fraud or mislabeling – a trend that first took hold in the food sector...

United States Healthcare

HK

Holland & Knight

The Chatbot Will See You Now: Utah Pilot Program Allows AI To Renew Prescriptions

United States Healthcare

DS

Dinsmore & Shohl

6 Key Federal Health Law Changes In 2025 And Their 2026 Impact

United States Healthcare

DW

Dickinson Wright PLLC

FDA Announces Third Year Of Voluntary Quality Management Maturity (QMM) Prototype Assessment Program

United States Healthcare

AP

Arnold & Porter

CMS ACCESS Model Update: Payment Rates And Performance Targets Released For 2026–2027

United States Healthcare

AF

ArentFox Schiff

FDA To Allow New 'No Artificial Colors' Labeling Claims

United States Healthcare

AF

ArentFox Schiff

Four Takeaways From The Business Of Healthcare Conference At The University Of Miami Herbert Business School

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Florida Proposes Changes To Medical Director Requirements For Nursing Homes

United States Healthcare

GT

Greenberg Traurig, LLP

Cognitive Dissonance: State And Federal Enforcers' Case Against Brain Health Dietary Supplement Due For Oral Arguments At The Second Circuit

United States Healthcare

M

Mintz

New Orleans ABO Renewal Season: Are You Ready?

United States Healthcare

Aa

Adams and Reese

From Indictment To Dismissal

United States Healthcare

KM

Katten Muchin Rosenman LLP

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Virginia Sues PBMs And Insulin Manufacturers Over Inflated Pricing Scheme

The Commonwealth of Virginia has filed suit against various pharmacy benefit managers (PBMs) and insulin manufacturers for allegedly violating the Virginia Consumer Protection Act. According to the lawsuit, the defendants...

United States Consumer

HB

Hall Benefits Law

Consolidated Appropriations Act Of 2026 Requires Greater Transparency By Pharmacy Benefit Managers

On February 3, 2026, Congress passed and President Trump signed into law the Consolidated Appropriations Act of 2026 (CAA).

United States Healthcare

GB

Genova Burns

California Food Fight: The SF City Attorney's Snack Attack

San Francisco's City Attorney has sued 11 major food companies, alleging they engineered ultra-processed foods to be addictive, concealed health risks, and targeted children and minority communities...

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Authenticity in Alcohol Labeling: What's Brewing?

United States Healthcare

HK

Holland & Knight

6 Key Federal Health Law Changes In 2025 And Their 2026 Impact

United States Healthcare

DW

Dickinson Wright PLLC

Recent Developments In Law And Policy Regarding The Food Supply Chain, Agricultural Land Ownership, And Antitrust Investigations

United States Government

WR

Wiley Rein

FDA Announces Third Year Of Voluntary Quality Management Maturity (QMM) Prototype Assessment Program

United States Healthcare

AP

Arnold & Porter

Cannabis In 2026 – Part III: What Schedule III Could Mean For State-Legal Cannabis Operations: Real Upside, Persistent Friction

United States Cannabis

SM

Sheppard, Mullin, Richter & Hampton LLP

FDA To Allow New 'No Artificial Colors' Labeling Claims

United States Healthcare

AF

ArentFox Schiff

See more

Life Sciences, Biotechnology & Nanotechnology

One-Way NDA vs. Mutual NDA For Life Sciences And Other Technology Companies: A Founder's Decision Guide

When you need to share sensitive information with a potential investor or business partner, a nondisclosure agreement ("NDA"), sometimes called a confidential disclosure agreement, is often the first contract on the table.

United States IP

C

Crowley Law LLC

FDA Announces Third Year Of Voluntary Quality Management Maturity (QMM) Prototype Assessment Program

On February 11, 2026, the U.S. Food and Drug Administration (FDA or the Agency) published a Federal Register notice announcing an opportunity for nine drug manufacturing establishments to participate...

United States Healthcare

AP

Arnold & Porter

MHRA Launches Targeted Consultation On Indefinite Recognition Of CE‑Marked Medical Devices

Today, 16 February 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) opened an important consultation seeking views on proposed changes to the recognition of CE‑marked medical devices...

United States Healthcare

AP

Arnold & Porter

"The Great American Recovery Initiative": What President Trump's New Executive Order Means For Behavioral Health Providers

United States Healthcare

FL

Foley & Lardner

"Innovation: The Intersection Of Biotech, Patent Law, And AI With Dr. Kate Neville, IP Attorney"

United States IP

MG

Marshall, Gerstein & Borun LLP

Shareholder Activism In Life Sciences: Risks, Responses, And Outlook

United States Commercial

GP

Goodwin Procter LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Video)

United States Healthcare

W

WilmerHale

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

United States Healthcare

W

WilmerHale

FDA Announces New Enforcement Policy On "No Artificial Colors" Food Labeling

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

See more

Healthcare

OIG Advisory Opinion 25-12

The Office of Inspector General ("OIG") recently issued OIG Advisory Opinion 25-12 (the "Opinion") addressing a home care agency's ("Agency's") plan to offer and advertise sign...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Consolidated Appropriations Act Of 2026 Requires Greater Transparency By Pharmacy Benefit Managers

On February 3, 2026, Congress passed and President Trump signed into law the Consolidated Appropriations Act of 2026 (CAA).

United States Healthcare

GB

Genova Burns

The Chatbot Will See You Now: Utah Pilot Program Allows AI To Renew Prescriptions

Utah has taken the unprecedented move of permitting artificial intelligence (AI) to legally prescribe renewal medical prescriptions without human intervention.

United States Healthcare

DS

Dinsmore & Shohl

6 Key Federal Health Law Changes In 2025 And Their 2026 Impact

United States Healthcare

DW

Dickinson Wright PLLC

Follow The Money: DOJ Secures First Conviction Of A Banker For Laundering Healthcare Fraud Proceeds

United States Criminal

AP

Arnold & Porter

CMS ACCESS Model Update: Payment Rates And Performance Targets Released For 2026–2027

United States Healthcare

AF

ArentFox Schiff

FDA To Allow New 'No Artificial Colors' Labeling Claims

United States Healthcare

AF

ArentFox Schiff

Four Takeaways From The Business Of Healthcare Conference At The University Of Miami Herbert Business School

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Healthcare Sector Pushes For H-1B Exemptions

United States Immigration

FH

Foley Hoag LLP

See more

Latest Videos

See more

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Pay Transparency + The Power Of Preventive Strategies: Episode 3 — Pivoting Toward Preparation In The Life Sciences (Video)

JL

Jackson Lewis P.C.

Episode 37: Chanda Center For Health: Reimagining Access To And Delivery Of Long-term Disability Care (Podcast)

FL

Foley & Lardner

When Health Plans Become Health Leaders: Hillary Galyean Rewrites The Health Plan Playbook (Video)

AM

Alvarez & Marsal

Upcoming Events

Health Privacy Law Compliance – Florida & Federal Update 2026

United States Healthcare

HK

Holland & Knight

Women Future Forward

United States Healthcare

FH

Foley Hoag LLP

The Town Hall Table: From State Chapters To The U.S. Capitol

United States Healthcare

HK

Holland & Knight

You're Invited – New And Proposed CMS Models: What You Need To Know Now

United States Healthcare

HK

Holland & Knight

Reception During 2026 Expo West

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Mintz Biotech Reception

United States Healthcare

M

Mintz

Institute On Medicare And Medicaid Payment Issues

United States Healthcare

FL

Foley & Lardner

ACH’s 2026 Annual Meeting

United States Healthcare

FH

Foley Hoag LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More